Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Vistagen TherapeuticsTeligentRitter PharmaceuticalsPharmaxisBio-Path
Price Information
Current Price$0.53$2.59$4.10$0.68$5.07
52 Week RangeHoldHoldN/AN/ABuy
Beat the Market™ Rank
Overall Score1.
Analysis Score3.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationHoldHoldN/AN/ABuy
Consensus Price Target$0.85N/AN/AN/A$18.00
% Upside from Price Target60.08% upsideN/AN/AN/A255.03% upside
Trade Information
Market Cap$29.62 million$13.92 million$189.23 million$17.91 million$18.72 million
Average Volume1,297,228103,94814,227,7276970,575
Sales & Book Value
Annual RevenueN/A$65.90 millionN/A$39.41 million$40,000.00
Price / SalesN/A0.21N/A0.45467.71
CashflowN/AN/AN/A$0.23 per shareN/A
Price / CashN/AN/AN/A2.90N/A
Book Value$0.17 per share($0.99) per share$0.10 per shareN/A$7.31 per share
Price / BookN/A-2.61N/A0.69
Net Income$-24,590,000.00$-25,120,000.00$-10,130,000.00$4.97 million$-8,600,000.00
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/A
Net MarginsN/A-71.80%N/AN/AN/A
Return on Equity (ROE)N/A-682.10%N/AN/A-56.95%
Return on Assets (ROA)-230.71%-13.88%-162.05%N/A-52.33%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/AN/AN/AN/A0.02%
Current Ratio0.47%2.86%3.67%N/A12.09%
Quick Ratio0.47%1.23%3.67%N/A12.09%
Ownership Information
Institutional Ownership Percentage4.83%35.77%0.84%N/A9.73%
Insider Ownership Percentage12.34%20.53%15.40%N/A1.84%
Shares Outstanding55.77 million5.39 million46.15 million26.33 million3.69 million
Next Earnings Date8/21/2020 (Estimated)8/3/2020 (Estimated)8/12/2020 (Estimated)N/A8/20/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.